# CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma

> **NCT04726501** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Children's Cancer Group, China** · enrollment: 200 (estimated)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **OTHER:** Combined chemotherapy with or without involved-field radiotherapy

## Key facts

- **NCT ID:** NCT04726501
- **Lead sponsor:** Children's Cancer Group, China
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04726501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04726501, "CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04726501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*